Felix Walter Friedrich (Felix W Friedrich)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Prognostic Factors

Top Venues

Journal of cardiovascular pharmacology and therapeutics

Future oncology (London, England)

Scientific reports

The Journal of physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Susanna Hegewisch-Becker, Karsten Kratz-Albers, Jan Wierecky, Steffen Gerhardt, Daniel Reschke, Jens Borchardt, Ralf Reichelt, Felix Walter Friedrich
Current treatment landscape of pancreatic cancer patients in a network of office-based oncologists in Germany. Future oncology (London, England) (2022)
Claus F Vogelmeier, Joanna Diesing, Nils Kossack, Marc Pignot, Felix Walter Friedrich
COPD Exacerbation History and Impact on Future Exacerbations - 8-Year Retrospective Observational Database Cohort Study from Germany. International journal of chronic obstructive pulmonary disease 16 (2021)
Tjark F Schwemer, Navina Deutscher, Nadine Diermann, Rainer Böger, Edzard Schwedhelm, Stefan Blankenberg, Felix Walter Friedrich
Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF2α in patients with myocardial infarction in the randomized RIMINI-Trial. Scientific reports 9 (1) (2019)
Tjark F Schwemer, Lukas Radziwolek, Navina Deutscher, Nadine Diermann, Susanne Sehner, Stefan Blankenberg, Felix Walter Friedrich
Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial. Journal of cardiovascular pharmacology and therapeutics 24 (1) (2018)
Frederik Flenner, Birgit Geertz, Silke Reischmann-Düsener, Florian Weinberger, Thomas Eschenhagen, Lucie Carrier, Felix Walter Friedrich
Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice. The Journal of physiology 595 (12) (2017)